Pharmaceutical Fill and Finish Outsourcing Market Analysis, Size, and Growth (2022-2028)
Pharmaceutical Fill and Finish Outsourcing Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2.66 Billion |
| Market Size by 2028 | US$ 4.01 Billion |
| Global CAGR (2021 - 2028) | 6.1% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By State of Finished Products
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
Pharmaceutical Fill and Finish Outsourcing Market
The global pharmaceutical fill and finish outsourcing market is segmented based on the state of finished products, and content. Based on state of finished products, the market is categorized into liquids, solids, and semi-solids. By content, the market is segmented into organic substances isolated from microorganisms, organic substances isolated from animals, and inorganic substances. Based on regions, the global pharmaceutical fill and finish outsourcing market is segmented into North America, Europe, Asia Pacific, South and Central America and Middle East and Africa. The North America market is segmented into United States, Canada and Mexico. Europe market is segmented into France, Germany, Italy, Spain, United Kingdom and Rest of Europe. Asia Pacific is segmented into China, Japan, South Korea, India, Australia and Rest of Asia Pacific. Middle East and Africa is segmented into South Africa, Saudi Arabia, UAE and Rest of Middle East and Africa. South and Central America is bifurcated into Brazil, Argentina and Rest of South and Central America.
Companies operating in the market are Abbott, TEVA PHARMACEUTICAL INDUSTRIES LTD, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Piramal Enterprises Ltd., MabPlex International Ltd, WOCKHARDT, Cytovance Biologics, Thermo Fisher Scientific Inc. (Patheon N.V), Boehringer Ingelheim International GmbH amongst others.
Get Free Sample For